Improving CAR-T Cell Therapies (Immunotherapy Documentary Part III)
The technologies that enable immunotherapies are playing an increasingly critical role in determining how the immune system of a patient will respond to a specific tumor. As immunotherapies become the standard of care for cancer treatments, previous research-use only technologies like Next Generation Sequencing, RNA-Seq, Multi-Parameter Flow Cytometry, and Imaging Mass Cytometry are now being used in clinical setting. The effectiveness of these tools is vital. In this documentary, Biocompare taps the expertise of key opinion leaders, including Craig Monell, VP of Business Operations, BioLegend, to explore how immunotherapies and their supporting technologies are transforming patient care.
Видео Improving CAR-T Cell Therapies (Immunotherapy Documentary Part III) канала BioLegend
Видео Improving CAR-T Cell Therapies (Immunotherapy Documentary Part III) канала BioLegend
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Introduction to Immunotherapy (Immunotherapy Documentary Part I)](https://i.ytimg.com/vi/8Z0Gyv-3NL8/default.jpg)
![CAR T-cell therapy: Reprogramming the immune system to treat cancer | Rob Weinkove | TEDxTauranga](https://i.ytimg.com/vi/rZRsqin3lwY/default.jpg)
![A "living drug" that could change the way we treat cancer | Carl June](https://i.ytimg.com/vi/7qWvVcBZzRg/default.jpg)
![Automated CAR T cell manufacturing](https://i.ytimg.com/vi/PFWoVN5wafo/default.jpg)
![Adoptive T-cell Therapy: The Next Generation - Cassian Yee, M.D.](https://i.ytimg.com/vi/SI-F11HszLc/default.jpg)
![Cell Therapy Manufacturing Explained](https://i.ytimg.com/vi/lEJXzTULVkI/default.jpg)
![How to biohack your cells to fight cancer - Greg Foot](https://i.ytimg.com/vi/Mt5C5fhuU_0/default.jpg)
![The 8 Steps of CAR T-Cell Therapy](https://i.ytimg.com/vi/WN6TfgDMdFc/default.jpg)
![CAR T-Cell Therapy for Multiple Myeloma](https://i.ytimg.com/vi/Oyv5QogoJhw/default.jpg)
![#CIRMSymposium: Clinical Trial of IL13r CAR T Cells for Glioblastoma - Behnam Badie](https://i.ytimg.com/vi/YJ_ube-5Q9A/default.jpg)
![Updates in Multiple Myeloma from ASCO 2020](https://i.ytimg.com/vi/xQ2ZXlNhUr8/default.jpg)
![CAR T-Cell Therapy: How Does It Work?](https://i.ytimg.com/vi/OadAW99s4Ik/default.jpg)
![Simplifying GMP CAR T and CAR NK cell therapy manufacturing processes [WEBINAR]](https://i.ytimg.com/vi/OThRND_fNRc/default.jpg)
![Tumor Immunoprofiling and the Tumor Microenvironment (Immunotherapy Documentary Part II)](https://i.ytimg.com/vi/IFrO54UmbIE/default.jpg)
![Understanding CAR T-Cell Therapy for Lymphoma with Andrew Zelenetz, MD, PhD](https://i.ytimg.com/vi/UluDAM-EObk/default.jpg)
![Car T-Cell Therapy & Conjugated BCMA Monoclonal Antibodies](https://i.ytimg.com/vi/qZILsh2FOME/default.jpg)
![AbLearning™ - Episode 4: Chimeric Antigen Receptor T Cell Therapy: Efficacy & Safety](https://i.ytimg.com/vi/bcpoO4yT97U/default.jpg)
![CAR T-Cell Therapy: Side Effects](https://i.ytimg.com/vi/rIPlBrmMnoA/default.jpg)
![Understanding CAR T Cell Therapy and Lymphoma - March 2, 2021](https://i.ytimg.com/vi/QSsBuRdC6XI/default.jpg)
![Manufacturing CAR-T Cell Therapies: The Novartis Approach](https://i.ytimg.com/vi/Cmft6Sg8X3o/default.jpg)